Neeraj Agarwal

94PUBLICATIONS
435CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (94)

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Jun 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

|May 29, 2026
Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk.

|Mar 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate Cancer.

Rana R McKay, Shayan S Nazari, Andrew Elliott

|Dec 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Soumyajit Roy, Yilun Sun, Maha Hussain

|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

Pageof 16

Frequent Collaborators

24 joint publications

Umang Swami

15 joint publications

Nicolas Sayegh

10 joint publications

Georges Gebrael

7 joint publications

Emmanuel S Antonarakis